Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Acorda Therapeutics Inc
Acorda Therapeutics Inc_20131212
  

Acorda Therapeutics Inc patents

Recent patent applications related to Acorda Therapeutics Inc. Acorda Therapeutics Inc is listed as an Agent/Assignee. Note: Acorda Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Acorda Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Acorda Therapeutics Inc-related inventors




Date Acorda Therapeutics Inc patents (updated weekly) - BOOKMARK this page
11/23/17Chimeric protein
11/09/17Compositions and methods for extended therapy with aminopyridines
11/02/17Compositions and kits for the removal of irritating compounds from bodily surfaces
10/05/17Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
09/28/17Methods of using sustained release aminopyridine compositions
09/21/17Durable treatment with 4-aminopyridine in patients with demyelination
09/07/17Compositions and methods for treatment during non-acute periods following cns neurological injury
07/27/17Sustained release aminopyridine composition
07/27/17Methods of using sustained release aminopyridine compositions
06/15/17Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine
06/01/17Intranasal benzodiazepine pharmaceutical compositions
05/18/17Proteoglycan degrading mutants for treatment of cns
03/16/17Methods of using sustained release aminopyridine compositions
03/02/17Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
02/09/17Durable treatment with 4-aminopyridine in patients with demyelination
02/02/17Compositions and methods of using chondroitinase abci mutants
01/12/17Carbonate prodrugs and methods of using the same
01/12/17Compositions and methods of using chondroitinase abci mutants
12/22/16Method for achieving desired glial growth factor 2 plasma levels
12/01/16Use of neuregulin to treat peripheral nerve injury
11/10/16Hepatoprotectant acetaminophen mutual prodrugs
10/20/16Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine
09/29/16Compositions and methods for promoting neuronal outgrowth
09/15/16Methods for detecting cardiac damage
09/15/16Water-soluble acetaminophen analogs
07/28/16Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
07/14/16Methods of using sustained release aminopyridine compositions
06/30/16Durable treatment with 4-aminopyridine in patients with demyelination
05/12/16Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure
04/28/16Methods for treating congestive heart failure
04/28/16Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
03/10/16Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine
03/10/16Methods for treating a stroke-related sensorimotor impairment using aminopyridines
03/03/16Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines
02/04/16Method of reducing somnolence in patients treated with tizanidine
01/28/16Carbonate prodrugs and methods of using the same
11/12/15Compositions and methods of using chondroitinase abci mutants
11/05/15Compositions and methods for extended therapy with aminopyridines
10/22/15Fusion proteins for the treatment of cns
10/01/15Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
09/10/15Formulation for the treatment of pain
08/06/15Use of a neuregulin to treat peripheral nerve injury
07/09/15Compositions and methods of using chondroitinase abci mutants
04/16/15Compositions and kits for the removal of irritating compounds from bodily surfaces
04/02/15Use of neuregulin to treat peripheral nerve injury
03/19/15Methods of using sustained release aminopyridine compositions
03/12/15Methods and compositions for administration of trpv1 agonists
02/05/15Method of increasing the extent of absorption of tizanidine
01/22/15Compositions and methods for promoting neuronal outgrowth
12/25/14Methods for detecting cardiac damage
11/20/14Method of reducing somnolence in patients treated with tizanidine
10/30/14Proteoglycan degrading mutants for treatment of cns
09/04/14Compositions and methods for the treatment of cns injuries
08/14/14Carbonate prodrugs and methods of using the same
07/24/14Durable treatment with 4-aminopyridine in patients with demyelination
07/10/14Methods of reducing extravasation of inflammatory cells
02/06/14Methods of using sustained release aminopyridine compositions
12/12/13Methods of using sustained release aminopyridine compositions
11/21/13Sustained release aminopyridine composition
09/19/13Chimeric protein
08/15/13Compositions and methods of using chondroitinase abci mutants
08/15/13Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine
04/04/13Methods for treating a stroke-related sensorimotor impairment using aminopyridines
03/21/13Methods of using sustained release aminopyridine compositions
02/14/13Methods for treating congestive heart failure
Patent Packs
08/23/12Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
06/28/12Methods of using sustained release aminopyridine compositions
02/16/12Sustained release aminopyridine composition
02/02/12Compositions and methods for extended therapy with aminopyridines
11/03/11Compositions and methods for treatment during non-acute periods following cns neurological injury
07/07/11Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or pro-phylaxis of heart failure
05/26/11Use of a neuregulin to treat peripheral nerve injury
04/14/11Methods for detecting cardiac damage
09/23/10Compositions and methods of using chondroitinase abci mutants
03/11/10Methods of using sustained release aminopyridine compositions
10/01/09Glial mitogenic factors, their preparation and use
04/23/09Compositions and methods of using chondroitinase abci mutants
03/05/09Method of increasing the extent of absorption of tizanidine
12/12/13Methods of using sustained release aminopyridine compositions







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Acorda Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Acorda Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';